Format

Send to

Choose Destination
Curr Opin Nephrol Hypertens. 2000 Jul;9(4):395-402.

Hepatocyte growth factor in renal regeneration, renal disease and potential therapeutics.

Author information

1
Department of Oncology, Biomedical Research Center, Osaka University Graduate School of Medicine, Suita, Japan.

Abstract

Hepatocyte growth factor (HGF) has mitogenic, motogenic, morphogenic, and anti-apoptotic activities on renal cells and is a potential renotropin for renal protection and repair. In chronic renal failure/fibrosis, HGF in the kidney declines in a reciprocal manner to the increase in transforming growth factor-beta (TGF-beta). Neutralization of HGF by the antibody leads to acceleration of renal failure/fibrosis while HGF administration leads to remarkable attenuation, thus indicating the importance of HGF versus TGF-beta counterbalance in both pathogenesis and therapeutics in cases of chronic renal failure. HGF is being strongly considered for potential treatment of acute and chronic renal failure.

PMID:
10926176
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center